Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Abbott Gains US Approval For Pro Version Of Flash Glucose System

Executive Summary

The FreeStyle Libre Pro is intended to provide health-care providers with an easy-to-read visual summary of a diabetic patient's glucose data. Abbott has also filed for approval with FDA for a consumer-targeted version of the device.

Advertisement

Related Content

US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices
US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G
Abbott Earns CE Mark For FreeStyle Libre Bloodless Glucose Monitor

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT103893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel